Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP
暂无分享,去创建一个
Andreas Hartmann | E. Hirsch | A. Hartmann | K. Parain | J. Launay | E. Rousselet | S. Hunot | F. Pérez-Diaz | J. Callebert | Stéphane Hunot | Etienne C. Hirsch | Karine Parain | Fernando Perez-Diaz | Chantal Joubert | C. Cohen-Salmon | Jean-Marie Launay | Estelle Rousselet | Jacques Callebert | Claude Jacque | Charles Cohen-Salmon | C. Jacque | C. Joubert | Estelle Rousselet
[1] G. Rozas,et al. Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test , 1997, Brain Research.
[2] W. Wold,et al. Inhibition of tumor necrosis factor and interferon triggered responses by DNA viruses. , 1998, Seminars in cell & developmental biology.
[3] C. Brosnan,et al. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.
[4] M. Malim,et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Scheurich,et al. Tumor necrosis factor (TNF) receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1 , 1998, European journal of immunology.
[6] R. Zinkernagel,et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.
[7] D. Wallach,et al. Inhibition of Tumor Necrosis Factor Alpha (TNFα) Activity in Rat Brain is Associated with Cerebroprotection after Closed Head Injury , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] J. McHowat,et al. Stimulation of different phospholipase A2 isoforms by TNF-α and IL-1β in adult rat ventricular myocytes. , 1998, American journal of physiology. Heart and circulatory physiology.
[9] G. Nuovo,et al. AIDS Dementia Is Associated with Massive, Activated HIV-1 Infection and Concomitant Expression of Several Cytokines , 1996, Molecular medicine.
[10] J. Merrill,et al. Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.
[11] J Q Trojanowski,et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Mattson,et al. Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD , 1999, Journal of Neuroimmunology.
[13] K. Unsicker,et al. Screening of interleukins for survival-promoting effects on cultured mesencephalic dopaminergic neurons from embryonic rat brain. , 1995, Brain research. Developmental brain research.
[14] E. Hirsch,et al. FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells , 1999, The Journal of Neuroscience.
[15] J. Kimura,et al. Glial expression of cytokines in the brains of cerebrovascular disease patients , 1996, Acta Neuropathologica.
[16] F. Cambi,et al. 5′ Flanking DNA Sequences Direct Cell‐Specific Expression of Rat Tyrosine Hydroxylase , 1989, Journal of neurochemistry.
[17] D. Goeddel,et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice , 1994, Nature.
[18] D. Brenner,et al. Prolonged activation of jun and collagenase genes by tumour necrosis factor-α , 1989, Nature.
[19] H. Hatanaka,et al. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures , 1991, Neuroscience.
[20] H. Gendelman,et al. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA , 1995, Molecular and cellular biology.
[21] S. Sprang,et al. The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. , 1990, The Journal of biological chemistry.
[22] M. Mattson,et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors , 1996, Nature Medicine.
[23] A. Członkowska,et al. The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse , 1999, Experimental Neurology.
[24] B. Beutler,et al. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. , 1988, Annual review of biochemistry.
[25] M. Mattson,et al. Activation of NF‐κB protects hippocampal neurons against oxidative stress‐induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration , 1997, Journal of neuroscience research.
[26] I. Nakano,et al. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1β and nerve growth factor in the striatum , 1998, Neuroscience Letters.
[27] N. Fausto,et al. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. , 1998, The American journal of pathology.
[28] T. Nagatsu,et al. Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease , 1996, Neuroscience Letters.
[29] M. Mattson,et al. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] P. Suter,et al. Both TNF receptors are required for direct TNF‐mediated cytotoxicity in microvascular endothelial cells , 1998, European journal of immunology.
[31] D. Brenner,et al. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. , 1994, The Journal of biological chemistry.
[32] Haruo Okado,et al. Tumor Necrosis Factor Induces Bcl-2 and Bcl-x Expression through NFκB Activation in Primary Hippocampal Neurons* , 1999, The Journal of Biological Chemistry.
[33] Richard J Smeyne,et al. Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus , 1999, Brain Research.
[34] Shuxian Hu,et al. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. , 1994, Developmental neuroscience.
[35] L. Old. Tumor necrosis factor. , 1988, Scientific American.
[36] P. Riederer,et al. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients , 1994, Neuroscience Letters.
[37] E. Hirsch,et al. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease , 1994, Neuroscience Letters.
[38] M. Mattson,et al. Exacerbation of Damage and Altered NF-κB Activation in Mice Lacking Tumor Necrosis Factor Receptors after Traumatic Brain Injury , 1999, The Journal of Neuroscience.
[39] D. Goeddel,et al. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism , 1988, Science.
[40] M. Mattson,et al. Brain injury and tumor necrosis factors induce calbindin D‐28K in astrocytes: Evidence for a cytoprotective response , 1995, Journal of neuroscience research.
[41] P. Blumberg,et al. Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli , 1997, Neuroreport.
[42] S. Kikuchi,et al. Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons , 1999, Brain Research.
[43] Y Agid,et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Tsunoda,et al. Effects of endotoxin and tumor necrosis factor α on regional brain neurotransmitters in mice , 1999 .
[45] A. Członkowska,et al. MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease. , 1999, Acta neurobiologiae experimentalis.
[46] L. Tartaglia,et al. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. , 1993, Journal of immunology.
[47] P. Mcgeer,et al. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.
[48] L. Sundstrom,et al. Attenuation and augmentation of ischaemia‐related neuronal death by tumour necrosis factor‐α in vitro , 2000, The European journal of neuroscience.
[49] S. Klahr,et al. Contributions of angiotensin II and tumor necrosis factor-α to the development of renal fibrosis , 2001 .
[50] H. Ichinose,et al. Increase in level of tumor necrosis factor (TNF)-α in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic l-DOPA on the TNF-α induction , 1999, Neuroscience Letters.
[51] D. Russell,et al. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. , 1995, Cytokine.
[52] T. Ben-Hur,et al. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant , 1997, Journal of Neuroimmunology.
[53] M. Mattson,et al. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis , 1994, Neuron.
[54] J. Langston,et al. Chapter 36: Astrocytes and Parkinson's disease , 1992 .
[55] W. Fiers,et al. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. , 1998, Journal of immunology.
[56] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[57] H. Hatanaka,et al. Selective acid vulnerability of dopaminergic neurons and its recovery by brain-derived neurotrophic factor , 1995, Brain Research.
[58] J. Gilmore,et al. Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro , 1997, International Journal of Developmental Neuroscience.
[59] L. Mucke,et al. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease , 1997, Brain Research Reviews.
[60] J. Merrill,et al. Cytokines in inflammatory brain lesions: helpful and harmful , 1996, Trends in Neurosciences.
[61] G. Wong,et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination , 1998, Nature Medicine.
[62] D. Walker,et al. Microglia in degenerative neurological disease , 1993, Glia.
[63] J. Elliott. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. , 2001, Brain research. Molecular brain research.
[64] B. Zalc,et al. Differential Oligodendroglial Expression of the Tumor Necrosis Factor Receptors In Vivo and In Vitro , 1995, Journal of neurochemistry.
[65] E. Hirsch,et al. Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease. , 1999, Advances in neurology.
[66] H. Nawashiro,et al. TNF-α Pretreatment Induces Protective Effects against Focal Cerebral Ischemia in Mice , 1997 .
[67] Minoru Harada,et al. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients , 1994, Neuroscience Letters.
[68] K. Murayama,et al. Simultaneous measurement of monoamines, metabolites and amino acids in brain tissue and microdialysis perfusates. , 1993, Journal of chromatography.
[69] N. Rothwell,et al. Cytokines in neurodegeneration and repair , 1995, International Journal of Developmental Neuroscience.
[70] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[71] D. Griffin,et al. In vitro evidence for a dual role of tumor necrosis factor‐α in human immunodeficiency virus type 1 encephalopathy , 1995, Annals of neurology.
[72] M. Karin,et al. Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.
[73] B. Aggarwal,et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.
[74] Luigi Aloe,et al. TNF-α expressed in the brain of transgenic mice lowers central tyroxine hydroxylase immunoreactivity and alters grooming behavior , 1997, Neuroscience Letters.
[75] P. Riederer,et al. Brain β2-microglobulin levels are elevated in the striatum in Parkinson's diseaselevels are elevated in the striatum in Parkinson's disease , 1995 .
[76] W. Lesslauer,et al. Tumor Necrosis Factor Receptors (Tnfr) in Mouse Fibroblasts Deficient in Tnfr1 or Tnfr2 are Signaling Competent and Activate the Mitogen-activated Protein Kinase Pathway with Differential Kinetics* , 1996, The Journal of Biological Chemistry.
[77] P. Carvey,et al. Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons , 2001, Experimental Neurology.
[78] P. Riederer,et al. Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease , 1995, Neuroscience Letters.
[79] J. Hoskins,et al. The acute effect on levels of catecholamines and metabolites in brain, of a single dose of MPTP in 8 strains of mice , 1989, Neuropharmacology.
[80] H. Loetscher,et al. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation. , 1994, Journal of immunology.